$LFMD Income Statement | Understand Stock

$LFMD

$2.12 +$0.04 (1.92%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenues, net
Telehealth
Work simpli
Telehealth Revenue
WorkSimpli Revenue
Total revenues, net

Cost of telehealth revenue
Telehealth
Work simpli
Telehealth Revenue
WorkSimpli Revenue
Total cost of telehealth revenue

Gross profit
Expenses
Selling and marketing expenses
General and administrative expenses
Customer service expenses
Other operating expenses
Development costs
Goodwill and intangible asset impairment charges
Change in fair value of contingent consideration
Total expenses

Operating loss from continuing operations
Interest expense, net
Loss on debt extinguishment
Loss from continuing operations before income taxes
Income tax provision
Net loss from continuing operations
Net income from discontinued operations
Net income (loss)
Net income attributed to the non-controlling interest
Net income (loss) attributable to LifeMD, Inc.
Preferred stock dividends
Net income (loss) attributable to LifeMD, Inc. common stockholders
Continuing operations
Discontinued operations
Basic earnings (loss) per share
Diluted earnings (loss) per share
Weighted average number of common shares outstanding:
Basic
Diluted

Comments